Skip to content
Clinical Trials – home
Not yet recruiting

Study of methylprednisolone effects on recovery after major surgery in elderly patients aged 60 and over

Verified siteRegistered drugNo placebo
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

What is this trial about?

A plain-language summary of the goals, design and what participants do

This clinical trial studies the effects of corticosteroids in elderly patients undergoing major surgery. The surgical procedures include robotic assisted laparoscopic radical prostatectomy, peripheral vascular surgery, coronary bypass surgery, thoracoscopic lung resection, laparoscopic colorectal surgery, and valve repair or replacement surgery. The study aims to evaluate how moderate doses of corticosteroids affect early recovery after these complex surgical procedures, with a particular focus on muscle weakness.

The treatment involves the use of methylprednisolone (Solu-Medrol), which is given through an intravenous injection. Patients will also receive sodium chloride solution (normal saline) as part of their treatment. The medication will be administered as a single dose on the day of surgery.

During the study, various aspects of recovery will be monitored, including muscle strength, lung function, pain levels, and overall quality of recovery. The study specifically focuses on patients who are 60 years of age or older, as this age group may have different recovery patterns and needs after major surgery.

The research process

The trial runs in 4 steps – from screening to follow-up. Each step says what happens and what the team monitors.

  1. Step 1

    Initial preparation

    You will be scheduled for a major surgery procedure, which may include one of the following: robotic prostate surgery, vascular surgery, heart bypass surgery, lung surgery, colorectal surgery, or heart valve surgery.

    Before the surgery, your medical condition and eligibility will be confirmed. You must be 60 years or older to participate in this study.

  2. Step 2

    Medication administration

    You will receive two medications through an intravenous line (a thin tube inserted into your vein):

    The first medication is Solu-Medrol (methylprednisolone), which is a corticosteroid given by injection

    The second medication is sodium chloride solution (salt water) given by infusion

  3. Step 3

    Assessments during recovery

    Your recovery will be monitored through several measurements:

    Assessment of muscle strength and function

    Evaluation of breathing capacity

    Completion of questionnaires about your mental status

    Rating of your fatigue levels

    Assessment of your pain levels using a scale from 0 to 10

    Monitoring for any feelings of nausea or vomiting

    Blood tests to check various health markers

  4. Step 4

    Quality of life evaluation

    You will complete questionnaires about:

    Your overall recovery experience

    Your general health and well-being

    Your daily activities and comfort levels

Who can join the trial?

9 criteria

  • You must be 60 years of age or older
  • You must be scheduled for one of these major surgical procedures:
    • Robotic prostate removal surgery (robotic assisted laparoscopic radical prostatectomies)
    • Leg blood vessel surgery (peripheral vascular surgery)
    • Heart bypass surgery with heart-lung machine (on pump coronary bypass)
    • Heart bypass surgery without heart-lung machine (off pump coronary bypass)
    • Minimally invasive lung surgery (thoracoscopic lung resection)
    • Minimally invasive colon or rectal surgery (laparoscopic colorectal surgery)
    • Minimally invasive heart valve surgery (valve repair or replacement)
    • Both men and women can participate

Who cannot join the trial?

16 criteria

  • Patients under 60 years of age cannot participate in the study
  • Patients who are not scheduled for one of these major surgeries:
    • Robotic prostate removal surgery (robotic assisted laparoscopic radical prostatectomy)
    • Leg blood vessel surgery (peripheral vascular surgery)
    • Heart bypass surgery (both on-pump and off-pump coronary bypass)
    • Minimally invasive lung surgery (thoracoscopic lung resection)
    • Minimally invasive colon and rectum surgery (laparoscopic colorectal surgery)
    • Minimally invasive heart valve repair or replacement
    • Patients who are currently participating in other clinical trials
    • Patients who have had major surgery within the last 30 days
    • Patients who are currently taking steroid medications or have taken them in the past 3 months
    • Patients with severe muscle weakness or neuromuscular disorders
    • Patients with severe heart, liver, or kidney problems
    • Patients with uncontrolled diabetes
    • Patients with active infections
    • Patients who are pregnant or breastfeeding
    • Patients who cannot provide informed consent
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

We usually reply within a few days

Verified sites

All sites with verified contact details – recruitment status may not be available; ask directly

Trial locations

Where you can join this trial

Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.

Not yet recruiting
Not finding your country?

Not sure what to do next?

Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.

See the full process and FAQ

Investigated drugs

Corticosteroids are medications that mimic the effects of hormones that your body naturally produces. In this trial, they are being studied to help elderly patients recover after major surgery. These medications can help reduce inflammation and support the body's stress response during and after surgical procedures. They may be particularly beneficial in preventing muscle weakness that often occurs after major operations in older patients.

What is already known about the treatment

Corticosteroids – A class of steroid medications administered before and during major surgery to potentially improve post-operative outcomes, particularly in elderly patients. These medications are typically given intravenously during the perioperative period and work by reducing inflammation and modulating the body's stress response to surgery. Corticosteroids function by binding to specific receptors in cells, suppressing inflammatory mediators and affecting various metabolic processes, which may help prevent post-operative complications and muscle weakness. These medications belong to the glucocorticoid class of drugs and are well-established in medical practice, being used in various surgical procedures including robotic, cardiac, and laparoscopic surgeries.

Investigated diseases

Based on the provided data, I will describe the relevant medical conditions that may occur after major surgeries: Post-operative Muscle Weakness - A condition where patients experience reduced muscle strength following surgery. It commonly affects elderly patients after major operations and can impact mobility and daily activities. The condition typically develops shortly after surgery and may affect various muscle groups throughout the body. Post-operative Fatigue Syndrome - A state of physical and mental exhaustion that occurs after major surgical procedures. Patients experience persistent tiredness, reduced energy levels, and difficulty performing routine tasks. This condition can last for several weeks after surgery. Post-operative Cognitive Dysfunction - A temporary decline in cognitive function that can occur after major surgery, particularly in elderly patients. It affects memory, attention, and information processing abilities. The condition may present as confusion, difficulty concentrating, or problems with short-term memory. Post-operative Nausea and Vomiting (PONV) - A common condition where patients experience feelings of sickness and vomiting after surgical procedures. It typically begins within the first 24 hours after surgery. The symptoms can range from mild to severe. Post-operative Respiratory Dysfunction - A condition affecting lung function after major surgery. Patients may experience reduced breathing capacity and efficiency. It commonly manifests as shallow breathing or difficulty taking deep breaths.
Trial detailsLast updated 2 Oct 2026
Age18+ yearsPhasePhase IIITrial ID2024-517602-28-00Estimated enrolment674 patientsSponsorZiekenhuis Oost Limburg

sourced from the EU Clinical Trials Register and site verification

Want to learn more about this trial or check if you can participate?

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).